Veterinary Vaccines Market Boosting the Growth 2026: Key Players Zoetis Inc. Merck Animal Health, Merial Inc., Boehringer Ingelheim, Bayer Animal Health

Rapid increase in population of companion animals and livestock animals globally is one of the major factors expected to favor market growth for veterinary vaccines. Rise in awareness about the vaccination programs are further favoring growth of the global veterinary vaccines market. The market is estimated to witness considerable revenue traction over the forecast period, due to increasing incidence of food-borne zoonotic diseases worldwide. Also, rise in demand for white meat in the North American and European countries is in turn expected to support growth of the veterinary vaccines market in the near future.

According to the PoultrySite - Poultry News, Health, Welfare, Diseases, Markets and Economics, in 2013, there was a significant rise in demand for white meat in Italy since a decade, with demand for turkey, chicken and eggs increased by 8.5%, while production of poultry increased by 16%.

Request Sample Copy of This Report: https://www.coherentmarketinsights.com/insight/request-sample/125

High prevalence of zoonotic diseases due to various factors such as environmental changes, demographics related to human and animals, pathogen, and modifications in farming practice is major factor driving growth of the market. According to Maine Center for Disease Control & Prevention, in 2013, around 75% diseases of animal origin affecting humans were infectious diseases. Animals should to be treated according to the severity of diseases, as they are human companions and serve as a source of meat and dairy products. The specificity of the vaccines is responsible for increasing demand for the veterinary vaccines that can be used as prophylaxis.

According to clinical microbiology paper published in 2007, veterinary vaccines comprise around 25% of the animal health products worldwide. Veterinary vaccines industry has witnessed significant traction, owing to various factors such as technological advancements in novel vaccine development methods, which is increasing adoption of the veterinary vaccines worldwide. Furthermore, drug resistance to existing pathogens and new diseases is propelling drug discoveries.

According to the Journal of American Veterinary Medical Association (JAVMA) 2017, veterinary vaccines market witnessed several acquisitions and mergers in order to gain maximum market share. However, 85 to 95% of veterinary hospitals in the U.S. are owned independently. Mars Incorporated—a company involved in manufacturing of Petcare, Chocolate, Wrigley, Food and Drinks—acquired VCA Inc. – a pet health care services provider in the U.S. and Canada that delivers around 800 small veterinary hospitals – in total value of around US$ 9.1 billion.

Furthermore, consolidation has been observed in the industry, as companies are focused on leveraging potential through economies of improved business practices. Furthermore, other factors responsible for growth of the veterinary vaccines market are increasing number of swine population worldwide globally, which is expected to fuel growth of the veterinary vaccines market over the forecast period.

Some of the major players are Zoetis Inc. Merck Animal Health, Merial Inc., Boehringer Ingelheim, Bayer Animal Health, Elanco Animal Health, Ceva Animal Health, Heska Corporation, Virbac Inc., and Indian Immunological Ltd.

Purchase Copy of This Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/125

Contact Us:

Mr. Raj Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.